Effect of Zoledronate on Bone Loss After Romosozumab/Denosumab: 2-Year Follow-up.

Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics